The hypoglycemic activity of glycyrrhizic acid (GA, I), its trisodium (II) and sodium-dilithium salts (III), and a conjugate with L-methionine methyl ester (IV) was studied using an alloxan diabetes model after peroral administration to male Wistar rats. It was found that GA and its conjugate IV at a dose of 100 mg/kg exhibited hypoglycemic activity and reduced the blood glucose content of the animals by 35.5 and 42.6%, respectively, after 120 min. GA conjugate IV had low toxicity and hypoglycemic activity superior to those of GA and acarbose.
Similar content being viewed by others
References
E. Adeghate, Open Med. Chem. J., 5, 68 – 69 (2011).
M. Stumvoll, B. J. Goldstein, and T. W. Van Haeften, Endocr. Res., 32(1 – 2), 19 – 37 (2007).
A. Artasensi, A. Pedretti, G. Vistoli, and L. Fumagalli, Molecules, 25(8), 1987 – 2007 (2020).
M. Hanefeld and F. Schaper, Expert Rev. Cardiovasc. Ther., 6, 153 – 163 (2008).
Y. D. Kim, K.-G. Park, Y.-S. Lee, et al., Diabetes, 57, 306 – 311 (2008).
E. Adeghate, H. Kalasz, G. Veress, and K. Tekes, Curr. Med. Chem., 17, 517 – 551 (2010).
S. R. Leicach and H. D. Chludil, Stud. Nat. Prod. Chem., 42, 267 – 304 (2014).
L.-T. Chang, Y.-Ch. Chen, H.-M. Chen, et al., Curr. Med. Chem., 20(7), 899 – 907 (2013).
Z. Yin, W. Zhang, F. Feng, et al., Food Sci. Hum. Wellness, 3, 136 – 174 (2014).
O. O. Elekofehinti, Pathophysiology, 22, 95 – 103 (2015).
G. A. Tolstikov, L. A. Baltina, V. P. Grankina, et al., Licorice: Biodiversity, Chemistry, and Use in Medicine [in Russian], Akademicheskoe Izd. Geo, Novosibirsk (2007).
K. Chen, R. Yang, F.-Q. Shen, and H.-L. Zhu, Curr. Med. Chem., 27, 6219 – 6243 (2020).
T. Tanahashi, T. Mune, H. Morita, et al., J. Steroid Biochem. Mol. Biol., 80, 441 – 447 (2002).
P. Anagnostis, N. Katsiki, F. Adamidou, et al., Metabolism, 62, 21 – 33 (2013).
C. Hale and M. Wang, Mini-Rev. Med. Chem., 8, 702 – 710 (2008).
I. Beseda, L. Czollner, P. S. Shah, et al., Bioorg. Med. Chem., 18, 433 – 454 (2010).
Y. Y. Chia, Sh. Y. Liong, So Ha Ton, and Kh. A. Kadir, Eur. J. Pharmacol., 677, 197 – 202 (2012).
H. Takii, T. Kometani, T. Nishimura, et al., Biol. Pharm. Bull., 24(5), 484 – 487 (2001).
S. Sen, M. Roy, and A. S. Chakraborti, J. Pharm. Pharmacol., 63(2), 287 – 296 (2011).
W. Zhang, T. Li, X.-J. Zhang, and Z.-Y. Zhu, Food Funct., 11, 4160 – 4170 (2020).
L.-Yu Wang, K. Ch. Cheng, Yi. Li, et al., Biomed. Pharmacother., 95, 599 – 604 (2017).
R. M. Kondratenko, L. A. Baltina, S. R. Mustafina, et al., Pharm. Chem. J., 35(2), 101 – 104 (2001).
R. M. Kondratenko, L. A. Baltina, L. R. Mikhailova, et al., Pharm. Chem. J., 39(2), 84 – 88 (2005).
L. A. Baltina, V. A. Davydova, T. G. Tolstikova, et al., Pharm. Chem. J., 25(3), 201 – 206 (1991).
A. J. Gordon and R. A. Ford, The Chemist’s Companion, Wiley-Interscience, New York (1972).
A. N. Mironov and N. D. Bunyatyan, Handbook for Preclinical Drug Trials, Part 1, Grif i K, Moscow (2013).
B. Zhao, F. Wu, X. Han, et al., Life Sci., 263, 118490 (2020).
O. N. Elizarova, Determination of Threshold Doses of Industrial Poisons for Peroral Administration [in Russian], Meditsina, Moscow (1971), pp. 47 – 48.
ACKNOWLEDGMENTS
The work was performed on State Task Topics AAAAA20-120012090026-9 and AAAA-A20-120012090029-0 and used equipment at the Khimiya CUC.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 55, No. 4, pp. 29 – 33, April, 2021.
Rights and permissions
About this article
Cite this article
Baltina, L.A., Sapozhnikova, T.A., Gabdrakhmanova, S.F. et al. Hypoglycemic Activity of Glycyrrhizic Acid and Some of its Derivatives in the Alloxan Diabetes Model in Rats. Pharm Chem J 55, 340–344 (2021). https://doi.org/10.1007/s11094-021-02424-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-021-02424-x